Physician profile
Mark Lee Capener
NPI 1750489100
$1,540.90
in general payments reported to CMS, 2019-2025
15 companies · $36.87 in 2025
The $36.87 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $351 · 2020: $266 · 2021: $330 · 2022: $281 · 2023: $110 · 2024: $166 · 2025: $36.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $313.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $481.89 | 2021-2025 | Propel, Sinuva, Nuvent |
| Medtronic USA, INC. | $307.64 | 2019-2020 | |
| Intersect Ent, INC. | $275.68 | 2019-2021 | |
| Stryker Corporation | $110.35 | 2019-2022 | |
| Abbvie INC. | $60.80 | 2021-2024 | |
| Optinose US, INC. | $58.36 | 2019-2022 | |
| Acclarent, INC | $44.90 | 2020-2022 | |
| Amgen INC. | $41.46 | 2022-2024 | Tavneos |
| Glaxosmithkline, LLC. | $37.50 | 2024 | Nucala |
| Novartis Pharmaceuticals Corporation | $31.11 | 2019 | |
| Inspire Medical Systems, INC. | $21.60 | 2024 | Inspire |
| Merck Sharp & Dohme LLC | $20.67 | 2023 | |
| Aerin Medical INC. | $18.41 | 2024 | |
| Hologic Sales and Service, LLC | $17.42 | 2022 | |
| Arbor Pharmaceuticals, INC. | $13.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Capener listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.